[
  {
    "ts": "2025-09-09T22:32:00+00:00",
    "headline": "Raymond James Announces Pricing of Offering of $1.5 Billion of Senior Notes",
    "summary": "St. Petersburg, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) (“Raymond James” or the “Company”) today announced the pricing of a registered underwritten public offering of (i) $650,000,000 aggregate principal amount of 4.900% senior notes due 2035 (the “2035 Notes”) and (ii) $850,000,000 aggregate principal amount of 5.650% senior notes due 2055 (the “2055 Notes” and, together with the 2035 Notes, the “Notes”). The 2035 Notes will bear interest at a rate of",
    "url": "https://finance.yahoo.com/news/raymond-james-announces-pricing-offering-223200060.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "abadca83-98f7-3af6-983a-72640b654cd1",
      "content": {
        "id": "abadca83-98f7-3af6-983a-72640b654cd1",
        "contentType": "STORY",
        "title": "Raymond James Announces Pricing of Offering of $1.5 Billion of Senior Notes",
        "description": "",
        "summary": "St. Petersburg, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James Financial, Inc. (NYSE: RJF) (“Raymond James” or the “Company”) today announced the pricing of a registered underwritten public offering of (i) $650,000,000 aggregate principal amount of 4.900% senior notes due 2035 (the “2035 Notes”) and (ii) $850,000,000 aggregate principal amount of 5.650% senior notes due 2055 (the “2055 Notes” and, together with the 2035 Notes, the “Notes”). The 2035 Notes will bear interest at a rate of",
        "pubDate": "2025-09-09T22:32:00Z",
        "displayTime": "2025-09-09T22:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/8286b53049f9f277202dccea5d1cc3d8",
          "originalWidth": 2409,
          "originalHeight": 531,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8Pg2by4dHUjgR3_biK9fHg--~B/aD01MzE7dz0yNDA5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/8286b53049f9f277202dccea5d1cc3d8.cf.webp",
              "width": 2409,
              "height": 531,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e5IViT9t_vneUXL8ZHVDLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8286b53049f9f277202dccea5d1cc3d8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/raymond-james-announces-pricing-offering-223200060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/raymond-james-announces-pricing-offering-223200060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RJF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-09T17:38:15+00:00",
    "headline": "CVS defended by Raymond James after stock drop",
    "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
    "url": "https://finance.yahoo.com/news/cvs-defended-raymond-james-stock-173815183.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "e92ae3ad-b3a0-3288-a499-a7c420ecb250",
      "content": {
        "id": "e92ae3ad-b3a0-3288-a499-a7c420ecb250",
        "contentType": "STORY",
        "title": "CVS defended by Raymond James after stock drop",
        "description": "",
        "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
        "pubDate": "2025-09-09T17:38:15Z",
        "displayTime": "2025-09-09T17:38:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-defended-raymond-james-stock-173815183.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-defended-raymond-james-stock-173815183.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "RJF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]